[Simultaneous determination of Ca 125 and D-dimer in plasma and ascites in ovarian cancer].
In 37 patients with ovarian carcinoma stages Ic to IV the values of preoperatively determined tumour markers and the values of the follow-ups were examined in a trial to observe the course of the disease. The following sensitivity was recorded: Ca 125 92%, D-dimer 100%, TPA 76%, CEA 29%, CA 19-9 15%. Ca 125, D-dimer and TPA are unsuitable as follow-ups. They are also detectable in ascites.
D002288:Adenocarcinoma, Mucinous / Q000276:immunology; D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D001201:Ascites / Q000276:immunology; D002277:Carcinoma / Q000276:immunology; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D010455:Peptides / Q000032:analysis; D019396:Tissue Polypeptide Antigen
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D005338:Fibrin Fibrinogen Degradation Products; D010455:Peptides; D019396:Tissue Polypeptide Antigen; C015214:fibrinogen D fragment
Die simultane Bestimmung von Ca 125 und D-Dimer im Plasma und Aszites beim Ovarialkarzinom.